CDKN2A and cancer: The PPI network for compounds 2–5 is visualized in Figure 13A. Importantly, TP53, PTEN, ATM, BRCA1, KRAS, CTNNB1, AKT, CDKN2A, ERBB2 and BRCA2 were identified as core compound 2–5 targets in cancer.